Early results from the RECOVERY trial in the UK are showing that steroid medicine dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19.
In this episode, NPS MedicineWise medical adviser and GP Dr Anna Samecki talks to NPS MedicineWise senior clinical program officer and pharmacist Rawa Osman to take an initial look at what the preliminary results may show, implications for practice in Australia, and some tips on how to have conversations with patients about these findings.
